Fingerprint
Dive into the research topics of 'A phase 2 trial of verubulin for recurrent glioblastoma: A prospective study by the brain tumor investigational consortium (BTIC)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 2 trial of verubulin for recurrent glioblastoma: A prospective study by the brain tumor investigational consortium (BTIC)
Marc C. Chamberlain, Sean Grimm, Surasak Phuphanich, Larry Recht, Jay Z. Zhu, Lyndon Kim, Steve Rosenfeld, Camilo E. Fadul
Research output: Contribution to journal › Article › peer-review
47
Scopus
citations